Of 89 samples of cancer cells from ovarian cancer patients primary cultures representative of the cancer cell population could be established in 17. The clinical response to polychemotherapy was studied in relation to the inhibition of thymidine uptake by the cultured cells. Cultures of each patient's tumour were exposed to concentrations of the drugs the patients had been given for long enough to reproduce the area under the curve (AUC) of the plasma levels resulting from in vivo dosage. Full agreement was observed between the degree of thymidine uptake inhibition induced by at least one of the drugs administered to the cultured cells and the degree of clinical response. This approach may prove useful in pharmacological studies as a means of obtaining ovarian cancer cell populations representative of human tumours, even though the number of tumours that can be successfully evaluated in vitro is still too small to serve as a sound basis for prediction. © 1983 The Macmillan Press Ltd

Morasca, L., Erba, E., Vaghi, M., Ghelardoni, C., Mangioni, C., Sessa, C., et al. (1983). Clinical correlates of in vitro drug sensitivities of ovarian cancer cells. BRITISH JOURNAL OF CANCER, 48(1), 61-68 [10.1038/bjc.1983.157].

Clinical correlates of in vitro drug sensitivities of ovarian cancer cells

Mangioni C.;Landoni F.;
1983

Abstract

Of 89 samples of cancer cells from ovarian cancer patients primary cultures representative of the cancer cell population could be established in 17. The clinical response to polychemotherapy was studied in relation to the inhibition of thymidine uptake by the cultured cells. Cultures of each patient's tumour were exposed to concentrations of the drugs the patients had been given for long enough to reproduce the area under the curve (AUC) of the plasma levels resulting from in vivo dosage. Full agreement was observed between the degree of thymidine uptake inhibition induced by at least one of the drugs administered to the cultured cells and the degree of clinical response. This approach may prove useful in pharmacological studies as a means of obtaining ovarian cancer cell populations representative of human tumours, even though the number of tumours that can be successfully evaluated in vitro is still too small to serve as a sound basis for prediction. © 1983 The Macmillan Press Ltd
Articolo in rivista - Articolo scientifico
Adult; Aged; Altretamine; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms
English
61
68
8
Morasca, L., Erba, E., Vaghi, M., Ghelardoni, C., Mangioni, C., Sessa, C., et al. (1983). Clinical correlates of in vitro drug sensitivities of ovarian cancer cells. BRITISH JOURNAL OF CANCER, 48(1), 61-68 [10.1038/bjc.1983.157].
Morasca, L; Erba, E; Vaghi, M; Ghelardoni, C; Mangioni, C; Sessa, C; Landoni, F; Garattini, S
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/261197
Citazioni
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 11
Social impact